期刊文献+

脂联素和蛋白质二硫键异构酶在糖尿病心肌病中的作用研究进展 被引量:5

Role of Adiponectin and Protein Disulfide Isomerase in DCM:Progress in Research
下载PDF
导出
摘要 糖尿病心肌病(DCM)与多种心血管疾病相关,如:猝死、心律失常、心绞痛、心源性休克及心力衰竭等,是糖尿病患者死亡的主要原因之一。因DCM的发病机制复杂,目前尚无明确特效的治疗方案。脂联素是主要由脂肪细胞、心肌细胞分泌的能调控糖脂代谢、保护心肌和血管的细胞因子,其水平降低可导致糖尿病心肌易损性增加,是DCM发病机制之一。蛋白质二硫键异构酶(PDI)是一种多功能的特殊蛋白,也是调节脂联素合成、分泌及多聚体形成的重要蛋白。本文就PDI通过脂联素对DCM的作用进展予以综述。 Diabetic cardiomyopathy (DCM) asociated with many cardiovascular diseases such as sudden death, ar- rhythmia, stenocardia, cardiogenic shock, heart failure, etc, is one of the main causes of diabetic patients' deaths. Up to now, there is no specific therapeutic regimen for DCM because of its complex nosogenesis. Adiponectin ( APN ) is a cytokine regulating glucose and lipid metabolism and protecting the myocardium, blood vessels, secreted primarily by fat cells, heart cells. Depressed level of APN, a pathogenesis of DCM, can lead to increase of diabetic myocardial vulnerability. Protein disul- fide isomerase (PDI) , a special protein with multiple functions, is an important protein regulating synthesis, secretion muhimer formation. Therefore, this paper reviews the possible effect of PDI on DCM by APN.
出处 《中国全科医学》 CAS CSCD 北大核心 2014年第5期601-603,共3页 Chinese General Practice
基金 国家自然科学基金资助项目(81270282)
关键词 蛋白质二硫化物异构酶 脂联素 糖尿病心肌病 内质网应激 Protein disulfide -isomerase Adiponectin Diabetic cardiomyopathy Endoplasmie reticulum stress
  • 相关文献

参考文献27

  • 1Yang WY,Lu JM,Weng JP,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1101.
  • 2Voulgari C,Papadogiannis D,Tentolouris N.Diabetic cardiomyopathy:from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies[J].Vasc Health Risk Manag,2010,6:883-903.doi:10.2147/VHRM.S11681.
  • 3Gonon AT,Widegren U,Bulhak A,et al.Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase,Akt,and nitric oxide[J].Cardiovasc Res,2008,78(1):116-122.
  • 4Toldo S,Severino A,Abbate A,et al.The role of PDI as a survival factor in cardiomyocyte ischemia[J].Methods Enzymol,2011,489:47-65.doi:10.1016/B978-0-12-385116-1.00003-0.
  • 5Voulgari C.Diabetic cardiomyopathy:from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies[J].Vascular Health Risk Manag,2010,6:883-903.doi:10.2147/VHRM.S11681.
  • 6Tsutsui H,Kinugawa S,Matsushima S,et al.Oxidative stress in cardiac and skeletal muscle dysfunction associated with diabetes mellitus[J].J Clin Biochem Nutr,2011,48(1):68-71.
  • 7Boudina S,Abel ED.Diabetic cardiomyopathy,causes and effects[J].Rev Endocr Metab Disord,2010,11(1):31-39.doi:10.1007/s11154-010-9131-7.
  • 8Huang JP,Huang SS,Deng JY,et al.Impairment of insulin-stimulated Akt/GLUT4 signaling is associated with cardiac contractile dysfunction and aggravates I/R injury in STZ-diabetic rats[J].J Biomed Sci,2009,16:77.doi:10.1186/1423-0127-16-77.
  • 9Wu Q,Ortegon AM,Tsang B,et al.FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity[J].Mol Cell Biol,2006,26(9):3455-3467.
  • 10Duncan JG.Mitochondrial dysfunction in diabetic cardiomyopathy[J].BBA-Molecular Cell Research,2011,1813(7):1351-1359.

同被引文献52

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部